Embrex

Name

Embrex

Legal name

Zoetis Services LLC

Website

https://embrexbiodevices.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Poultry Vaccination Equipment

SIC

Farm Machinery & Equipment (3523)

akta.pro primary industry

Vaccine Delivery Devices & Administration (Injectors, Oral Baits, In-Ovo) (HLAMAKAK)

akta.pro secondary industries

Poultry Vaccines (HLAMAKAC), Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO) (HLAMAKAI), Autogenous (Herd-Specific) Vaccines (HLAMAKAF), Hatcheries & Chick Production (Day-Old Chicks, Pullets) (AFAEADAD)

Keywords

• In ovo vaccination equipment
• Poultry hatchery devices
• Egg-based vaccine manufacturing
• Biological vaccination systems
• Animal health automation

Headquarters

HQ city

Memphis

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Equipment Leasing: Embrex BioDevices are provided through lease agreements that include comprehensive service coverage. The lease model includes all scheduled maintenance, emergency service, process evaluations, training, and parts within one agreement.
2. In Ovo Vaccines: Zoetis provides a comprehensive portfolio of Poulvac vaccines and Poulvac Procerta vector vaccines approved for in ovo application, paired with the Embrex vaccination equipment.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Embrex designs, manufactures and supplies biological devices for two markets: Poultry BioDevices (Inovoject, Inovoject NXT and Egg Remover NXT) used by hatcheries to vaccinate eggs in ovo, and Vaccine Manufacturing Devices (VAI, VMI, VED, VEH, VEL, VEU) used by human flu and animal vaccine producers for end-to-end egg-based vaccine production. Equipment is delivered primarily under multi-year lease agreements that bundle scheduled maintenance, emergency service, training, parts, and access to in ovo vaccination experts.

Product overview

Embrex offers two distinct product lines for the poultry and vaccine manufacturing industries: Poultry BioDevices and Vaccine Manufacturing Devices (VMD). The Poultry BioDevices line includes the Inovoject NXT and Inovoject systems (in ovo vaccination equipment with dual-needle technology vaccinating up to 70,000 and 45,000 eggs per hour respectively), plus the Egg Remover NXT for egg candling. The VMD line provides end-to-end egg-based vaccine production solutions including the VAI (automatic), VMI (manual), VED (decapping), VEH (harvesting), VEL (loading), and VEU (unloading) devices. Both product families leverage Embrex's core in ovo injection technology and are backed by inclusive hatchery service and support from Zoetis.

Differentiator

Problem solved

Functional benefit

Brands

• Inovoject NXT: New generation of industry-leading in ovo vaccination technology featuring Embrex Accusight egg identification technology, Embrex Precixion injection tooling, and Haylo egg handling technology, vaccinating up to 70,000 eggs per hour.
• Inovoject
• Egg Remover NXT
• Vaccine Automatic Inovoject (VAI)
• Vaccine Manual Inovoject (VMI)
• Vaccine Egg Decapper (VED)
• Vaccine Egg Harvester (VEH)
• Vaccine Egg Loader (VEL)
• Vaccine Egg Unloader (VEU)

Quantifiable outcome

• Up to 100% injection-site accuracy with proper embryo development stage and recommended transfer time
• +5 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Scale indicators8 records

Recent moves4 records

Expansion highlights5 records

Direct peers

• Petersime: Petersime is a leading global manufacturer of incubators and hatchery equipment, offering integrated hatchery solutions that compete with Embrex at the hatchery level. Both companies supply mission-critical equipment to commercial poultry hatcheries worldwide.
• Pas Reform: Pas Reform is a Dutch hatchery technology company specializing in incubation, hatchery automation, and chick processing equipment. As a direct competitor in the hatchery equipment space, Pas Reform increasingly integrates vaccination solutions alongside its incubation systems.
• Jamesway Incubator Company: Jamesway designs and manufactures commercial hatchery incubators and hatchery equipment used by major poultry producers. It competes with Embrex and other hatchery tech providers for global poultry integrator capital expenditures.
• Ceva Santé Animale: Ceva is a major animal health company with a substantial poultry vaccine portfolio that includes in ovo vaccines. It is both a potential partner and competitor to Embrex in the in ovo vaccination space, paired with hatchery equipment suppliers.
• Chick Master Incubator Company: Chick Master is a US-based hatchery equipment manufacturer competing with Embrex/Petersime/Pas Reform for commercial hatchery installations globally, with growing integration of vaccination and chick processing modules.

Emerging players

• Vaxxinova: Vaxxinova is a specialty animal health company focused on autogenous and licensed vaccines for livestock and poultry. It competes with Zoetis/Embrex-adjacent poultry vaccine portfolios and could partner with competing hatchery equipment providers.

Broad incumbents

• Elanco Animal Health: Elanco is a leading global animal health company that, post-Bayer Animal Health acquisition, competes with Zoetis/Embrex in poultry vaccines and adjacent livestock health products.
• Phibro Animal Health: Phibro is a diversified animal health and nutrition company with a poultry vaccine and feed additive portfolio that competes broadly with Zoetis/Embrex in serving commercial poultry producers.
• Merck Animal Health (MSD Animal Health): Merck/MSD Animal Health is a global leader in animal health pharmaceuticals and vaccines, including poultry vaccines. While not a direct competitor in in ovo equipment, it competes in the broader poultry health solutions market.
• Boehringer Ingelheim Animal Health: Following its acquisition of Merial, Boehringer Ingelheim is one of the largest animal health companies globally, with a poultry vaccine portfolio that overlaps with Zoetis/Embrex and competes in the same hatchery vaccination market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/ZoetisUS
• YouTubeyoutube.com/user/veterinariansoncall
• Facebookfacebook.com/ZoetisCommitmenttoVeterinarians
• LinkedInlinkedin.com/company/embrex-inc.
• Instagraminstagram.com/zoetisus

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Embrex